StockWatch
·

EMMESSAR BIOTECH & NUTRITION LTD. Q4 FY25 Results

EMMESSAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue0.100.3%
Total Income0.7032.8%
Expenditure0.4411.4%
PBT0.2699.2%
Net Profit-0.07503.5%
OPM
NPM-9.75%1.83pp
EPS0.16433.3%
View full financials

Informational and educational content only. Not investment advice.